37: How to lead the fight against Brain Cancer with CEO of CNS Pharmaceuticals - John Climaco

In this episode I interviewed John Climaco, who is the CEO of CNS Pharmaceuticals. 

John is extremely passionate about innovation that makes people’s lives better. 

We discuss how his company’s new drug Berubicin is a game changer when it comes to fighting Brain Tumors.

For 15 years Mr. Climaco has served in leadership roles in a variety of healthcare companies. Recently Mr. Climaco served as the Executive Vice-President of Perma-Fix Medical S.A where he managed the development of a novel method to produce Technitium-99. 

Previously Mr. Climaco served as President and CEO of Axial Biotech, Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization

CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Some other things that we discuss on the podcast.

• What makes their pharmaceutical innovation stand out
• Why Glioblastoma is such a deadly disease
• Taking a project from idea to product to market
• How Cancer drugs work and why most of the conventional Cancer drugs don’t work for Brain cancer

Book recommendation

• The Bold and the Cold
• Hitlers first 100 days

Connect with John Climaco:-

• https://cnspharma.com
• https://www.linkedin.com/in/john-climaco-62477a1/ 
• https://www.linkedin.com/company/cnspharma/

If you enjoyed this episode then please subscribe, I will be interviewing other successful founders and investors to provide you a shortcut to success.

Follow instagram:- https://www.instagram.com/wantmoneygotmoney/